UKALL14: implementing genetics in ALL research

Anthony Moorman, PhD, of Newcastle University, Newcastle, UK, discusses the current UKALL14 trial (NCT01085617) for adults aged 25-65 with acute lymphoblastic leukemia (ALL). The trial is the first of... Author: VJHemOnc Added: 07/18/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts